To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MCCC2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
233 supporting clones for gene MCCC2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_022132.4   .a 1 to 3671 1 to 3671 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 3671/3671
(100 %)
0 diff
(100 %id)
BM754087 stomach .a 11 to 360 10 to 362       353/353
(100 %)
6 diff
(98.4 %id)
BM847435 myeloma .a 13 to 558 1 to 546       546/546
(100 %)
1 diff
(99.9 %id)
BM847275 myeloma .a 13 to 590 1 to 577       577/577
(100 %)
3 diff
(99.5 %id)
CN309718 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 15 to 752 1 to 738   tiling clone,   738/745
(99 %)
5 diff
(99.4 %id)
BI459938 testis .a 17 to 643 7 to 635       629/635
(99 %)
10 diff
(98.5 %id)
CR976691 T-Lymphocytes .a 18 to 878 1 to 861       861/861
(100 %)
1 diff
(99.9 %id)
AF310971   .a 19 to 2185 1 to 2167 exact tiling clone,   2167/2170
(99 %)
4 diff
(99.9 %id)
BE883392 leiomyosarcoma, uterus .a 21 to 673 1 to 653       653/653
(100 %)
4 diff
(99.4 %id)
CR985841 T-Lymphocytes .a 34 to 828 1 to 797       797/805
(99 %)
9 diff
(98.9 %id)
DN995524 breast cancer, Mammary gland (cancer tissue) .a 37 to 689 8 to 660       653/660
(98 %)
6 diff
(99.1 %id)
BP222389   .a 39 to 619 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
AA313322 colon .a 40 to 228 1 to 189       189/189
(100 %)
1 diff
(99.5 %id)
AB050049   .a 40 to 2054 1 to 2015 exact     2015/2016
(99 %)
3 diff
(99.9 %id)
AF301000   .a 40 to 2366 1 to 2325 exact     2325/2325
(100 %)
5 diff
(99.8 %id)
DB004750 breast, tumor tissue .a 44 to 747 2 to 705   capped   704/704
(100 %)
0 diff
(100 %id)
BU508876 leiomyosarcoma, uterus .a 46 to 941 1 to 904       904/932
(96 %)
21 diff
(97.8 %id)
CN309719 embryonic stem cells, cell lines H1, H7, andH9 .a 64 to 769 1 to 706       706/706
(100 %)
2 diff
(99.8 %id)
AF261884   .a 66 to 2368 1 to 2304 exact     2304/2304
(100 %)
8 diff
(99.7 %id)
AL523556 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 66 to 878 1 to 806       806/810
(99 %)
10 diff
(98.8 %id)
BX403128 Neuroblastoma Cot 25-normalized .a 66 to 1027 1 to 958       960/958
(100 %)
14 diff
(98.6 %id)
BI770158 pooled lung and spleen .a 69 to 872 1 to 804       804/807
(99 %)
5 diff
(99.4 %id)
AV702522 adrenal gland .a 71 to 747 1 to 675       675/675
(100 %)
12 diff
(98.3 %id)
BX376668 Neuroblastoma Cot 50-normalized .a 71 to 873 1 to 801       801/806
(99 %)
8 diff
(99.1 %id)
TI_57178220   .a 71 to 872 29 to 830       802/833
(96 %)
9 diff
(99.0 %id)
BU501066 eye, normal pigmented retinal epithelium .a 77 to 681 1 to 606       606/943
(64 %)
9 diff
(99.1 %id)
BC065027 Testis, embryonal carcinoma .a 81 to 2182 1 to 2102 exact available from MGC, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 2102/2102
(100 %)
2 diff
(100.0 %id)
BQ232884 embryonal carcinoma, cell line, testis .a 83 to 807 1 to 732       732/936
(78 %)
7 diff
(99.3 %id)
DA591126 lung .a 100 to 656 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
CN309716 embryonic stem cells, cell lines H1, H7, andH9 .a 118 to 418 1 to 301       301/301
(100 %)
0 diff
(100 %id)
TI_1948216181   .a 138 to 1043 132 to 1040       911/1382
(65 %)
33 diff
(97.7 %id)
TI_1948216337   .a 138 to 1041 132 to 1033   fully sequenced,   902/1033
(87 %)
18 diff
(98.3 %id)
CV023331 mixed .a 139 to 764 1 to 626       626/652
(96 %)
4 diff
(99.4 %id)
EL735073 mixed .a 139 to 762 1 to 623       623/662
(94 %)
2 diff
(99.7 %id)
AA465612 germinal center B cell .a 170 to 687 1 to 516       516/516
(100 %)
3 diff
(99.5 %id)
BE786755 large cell carcinoma, lung .a 310 to 1043 1 to 746       745/1038
(71 %)
41 diff
(96.1 %id)
CN309714 embryonic stem cells, cell lines H1, H7, andH9 .a 344 to 647 1 to 304       304/304
(100 %)
0 diff
(100 %id)
BG876026 colon .a 366 to 1036 1 to 668       668/668
(100 %)
10 diff
(98.6 %id)
BG876025 colon .a 421 to 960 21 to 562       542/565
(95 %)
8 diff
(98.6 %id)
BG479006 choriocarcinoma, placenta .a 481 to 1084 1 to 609       609/612
(99 %)
10 diff
(98.4 %id)
CN309715 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 489 to 1133 1 to 645       645/645
(100 %)
1 diff
(99.9 %id)
BE073382 breast .a 521 to 632 13 to 124       112/124
(90 %)
6 diff
(95.2 %id)
BG490569 large cell carcinoma, lung .a 525 to 1284 1 to 764       763/777
(98 %)
20 diff
(97.5 %id)
BI258139 cervical carcinoma cell line, cervix .a 663 to 1435 1 to 778       776/778
(99 %)
16 diff
(98.0 %id)
BG698749 skin .a 720 to 1551 1 to 832       833/832
(100 %)
6 diff
(99.3 %id)
BE002027 breast_normal .a 808 to 1120 12 to 329       316/347
(91 %)
21 diff
(94.0 %id)
CK819733 Islets of Langerhans, Pancreas .a 946 to 1532 1 to 587       587/587
(100 %)
1 diff
(99.9 %id)
BM129837 Islets of Langerhans, Pancreas .a 961 to 1542 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BF331860 breast .a 987 to 1203 171 to 388       218/388
(56 %)
7 diff
(98.2 %id)
TI_1948216338   .a 1011 to 1829 941 to 122   fully sequenced,   820/941
(87 %)
4 diff
(99.6 %id)
AW418507 2 pooled tumors (clear cell type), Kidney .a 1042 to 1210 169 to 1       169/169
(100 %)
0 diff
(100 %id)
TI_1948216182   .a 1042 to 1829 912 to 123       790/1231
(64 %)
4 diff
(99.7 %id)
BF222524 Prostate .a 1060 to 1210 151 to 1       151/151
(100 %)
2 diff
(98.7 %id)
BQ347985 head_neck .a 1071 to 1626 18 to 573       556/578
(96 %)
16 diff
(97.3 %id)
BQ316359 colon .a 1074 to 1699 1 to 626       626/626
(100 %)
5 diff
(99.3 %id)
CV334469 uterus_tumor .a 1092 to 1600 510 to 1     Submitted on the opposite strand 510/510
(100 %)
4 diff
(99.3 %id)
BG288409 bladder, transitional cell papilloma, cell line .a 1103 to 1774 1 to 673       673/964
(69 %)
6 diff
(99.4 %id)
AW842226 colon_normal .a 1140 to 1345 228 to 29       200/228
(87 %)
2 diff
(99.2 %id)
BU173239 eye, retinoblastoma .a 1252 to 2191 1 to 942       942/949
(99 %)
18 diff
(98.2 %id)
CN309723 embryonic stem cells, cell lines H1, H7, andH9 .a 1290 to 1880 1 to 591       591/591
(100 %)
0 diff
(100 %id)
BQ923729 eye, normal pigmented retinal epithelium .a 1332 to 2177 1 to 851       851/876
(97 %)
14 diff
(98.5 %id)
EC574236 Prostate .a 1335 to 1438 1 to 104       104/104
(100 %)
0 diff
(100 %id)
EC525730 Prostate .a 1336 to 1438 1 to 103       103/103
(100 %)
2 diff
(98.1 %id)
EC529675 Prostate .a 1336 to 1435 2 to 102       101/102
(99 %)
3 diff
(97.1 %id)
BF968693 adrenal cortex carcinoma, cell line, adrenal gland .a 1342 to 2158 1 to 814       814/917
(88 %)
22 diff
(97.7 %id)
AI740792 pooled .a 1370 to 1670 79 to 380     Submitted on the opposite strand 302/348
(86 %)
13 diff
(96.3 %id)
BQ302288 breast .a 1398 to 1946 1 to 547       547/557
(98 %)
10 diff
(98.3 %id)
BP358435 mammary gland .a 1421 to 2019 1 to 598       598/598
(100 %)
1 diff
(99.9 %id)
BP358524 mammary gland .a 1429 to 2019 1 to 589       589/589
(100 %)
3 diff
(99.5 %id)
BG292011 bladder, transitional cell papilloma, cell line .a 1436 to 2139 1 to 710       710/764
(92 %)
16 diff
(98.0 %id)
AK025591   .a 1438 to 3671 1 to 2234   tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 2234/2234
(100 %)
6 diff
(99.8 %id)
BP238795 Liver .a 1438 to 2010 1 to 573       573/573
(100 %)
8 diff
(98.7 %id)
BP251498 hippocampus .a 1442 to 2026 1 to 584       584/584
(100 %)
5 diff
(99.2 %id)
CN309722 embryonic stem cells, DMSO-treated H9 cellline .a 1448 to 2178 9 to 739   tiling clone,   731/739
(98 %)
6 diff
(99.2 %id)
CN309717 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1456 to 2225 8 to 778       771/778
(99 %)
8 diff
(99.0 %id)
DA602390   .a 1460 to 2038 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
AI949422 2 pooled tumors (clear cell type), Kidney .a 1477 to 2188 715 to 3       713/715
(99 %)
4 diff
(99.5 %id)
BU198596   .a 1491 to 2111 1 to 632       632/859
(73 %)
33 diff
(96.2 %id)
BX115524 liver and spleen .a 1535 to 2256 33 to 755       723/748
(96 %)
6 diff
(99.2 %id)
DA866523 Prostate .a 1537 to 2096 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
AL079298   .a 1542 to 2368 1 to 827       827/827
(100 %)
2 diff
(99.8 %id)
R88931 liver and spleen .a 1542 to 1935 1 to 395       395/395
(100 %)
3 diff
(99.3 %id)
CB055229 brain, glioblastoma (pooled) .a 1551 to 2122 10 to 582   fully sequenced,   573/582
(98 %)
8 diff
(98.7 %id)
AI423046 brain, glioblastoma (pooled) .a 1552 to 2185 635 to 1       635/635
(100 %)
2 diff
(99.7 %id)
TI_157596882   .a 1552 to 2182 726 to 87   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 640/1081
(59 %)
25 diff
(97.7 %id)
BM478647 embryonal carcinoma, cell line, testis .a 1562 to 2444 1 to 886       886/1069
(82 %)
12 diff
(98.9 %id)
TI_154004499   .a 1566 to 1971 502 to 97       406/673
(60 %)
3 diff
(99.6 %id)
DA518737 brain .a 1573 to 1885 2 to 314   capped   313/313
(100 %)
0 diff
(100 %id)
AW590726 pooled germ cell tumors .a 1573 to 1825 253 to 1       251/253
(99 %)
28 diff
(89.0 %id)
BG178390 adenocarcinoma, cell line, Prostate .a 1589 to 2333 1 to 745       745/1051
(70 %)
25 diff
(97.7 %id)
CB055228 brain, glioblastoma (pooled) .a 1596 to 2026 432 to 1   fully sequenced,   432/432
(100 %)
1 diff
(99.8 %id)
BM129533 Islets of Langerhans, Pancreas .a 1600 to 2185 592 to 7       586/592
(98 %)
0 diff
(100 %id)
EC448562 Prostate .a 1624 to 1729 1 to 99       99/99
(100 %)
6 diff
(94.0 %id)
N31952 placenta .a 1625 to 2182 563 to 1       563/568
(99 %)
13 diff
(97.8 %id)
BU753871 placenta .a 1625 to 2182 576 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 558/561
(99 %)
1 diff
(99.9 %id)
BP240822 Liver .a 1626 to 2196 1 to 571       571/571
(100 %)
5 diff
(99.2 %id)
DA131276 alzheimer cortex .a 1631 to 2187 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
BG993857 head_neck .a 1671 to 2271 1 to 600       600/647
(92 %)
13 diff
(98.0 %id)
CX758185 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1675 to 2410 1 to 736     Submitted on the opposite strand 736/736
(100 %)
1 diff
(99.9 %id)
CA310586 Human Lung Epithelial cells, lung .a 1684 to 2182 517 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 499/504
(99 %)
2 diff
(99.7 %id)
AW243485 Kidney .a 1687 to 1825 139 to 1       139/139
(100 %)
4 diff
(97.2 %id)
BI258727 cervical carcinoma cell line, cervix .a 1687 to 2566 1 to 882       882/949
(92 %)
36 diff
(96.3 %id)
BG183687   .a 1708 to 2185 1 to 478       478/885
(54 %)
7 diff
(99.3 %id)
BG185795   .a 1708 to 2185 1 to 478       478/904
(52 %)
4 diff
(99.6 %id)
BG200281   .a 1708 to 2178 1 to 471       471/471
(100 %)
3 diff
(99.4 %id)
BG207043   .a 1708 to 2185 1 to 479       479/893
(53 %)
5 diff
(99.5 %id)
BG217606   .a 1708 to 2182 1 to 475       475/955
(49 %)
6 diff
(99.4 %id)
BG186864   .a 1709 to 2182 1 to 474   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 474/474
(100 %)
4 diff
(99.2 %id)
BG198715   .a 1709 to 2182 1 to 474   AAA   474/544
(87 %)
2 diff
(99.7 %id)
BG211718   .a 1713 to 2185 35 to 508       474/945
(50 %)
11 diff
(98.9 %id)
BG212268   .a 1713 to 2182 486 to 18   AAA Submitted on the opposite strand 469/469
(100 %)
3 diff
(99.4 %id)
BG215480   .a 1718 to 2184 1 to 464       464/892
(52 %)
5 diff
(99.5 %id)
BF337092 brain, glioblastoma with EGFR amplification .a 1721 to 2405 1 to 715       715/1171
(61 %)
37 diff
(96.9 %id)
BG187367   .a 1722 to 2056 52 to 385       334/385
(86 %)
6 diff
(98.5 %id)
BX483414   .a 1723 to 2332 8 to 618       611/618
(98 %)
8 diff
(98.8 %id)
BF170866 blood .a 1749 to 1931 1 to 185       185/185
(100 %)
10 diff
(94.6 %id)
CF528842 placenta .a 1760 to 2182 440 to 18   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 423/424
(99 %)
1 diff
(99.8 %id)
AW195192 Kidney .a 1765 to 2182 418 to 1       418/418
(100 %)
7 diff
(98.4 %id)
DN913187   .a 1784 to 2181 399 to 2       398/411
(96 %)
0 diff
(100 %id)
DN913188   .a 1784 to 2181 12 to 409       398/410
(97 %)
2 diff
(99.6 %id)
EC485106 Prostate .a 1788 to 1888 115 to 12       104/115
(90 %)
0 diff
(100 %id)
AV660395 corresponding non cancerous liver tissue .a 1798 to 2182 1 to 385   AAA Submitted on the opposite strand 385/385
(100 %)
1 diff
(99.8 %id)
CN309720 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1805 to 2401 1 to 596       596/596
(100 %)
2 diff
(99.7 %id)
BE543045 cervical carcinoma cell line, cervix .a 1825 to 2349 1 to 521       521/630
(82 %)
7 diff
(98.9 %id)
BE543143 cervical carcinoma cell line, cervix .a 1825 to 2385 1 to 557       557/622
(89 %)
13 diff
(98.0 %id)
BF755611 colon .a 1829 to 2005 14 to 187       174/187
(93 %)
6 diff
(96.8 %id)
CN309721 embryonic stem cells, DMSO-treated H9 cellline .a 1841 to 2519 8 to 687       680/687
(98 %)
6 diff
(99.2 %id)
AA658285   .a 1852 to 2182 347 to 21   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 327/327
(100 %)
8 diff
(97.6 %id)
BF754745 colon .a 1853 to 2005 153 to 1     Submitted on the opposite strand 153/161
(95 %)
4 diff
(97.6 %id)
EC488619 Prostate .a 1864 to 1967 1 to 100       100/100
(100 %)
5 diff
(95.0 %id)
EC489642 Prostate .a 1870 to 1986 1 to 116       116/118
(98 %)
4 diff
(96.7 %id)
EC534852 Prostate .a 1908 to 2031 1 to 118       118/118
(100 %)
6 diff
(95.0 %id)
EH326435   .a 1911 to 1962 1 to 51       51/51
(100 %)
1 diff
(98.1 %id)
BX502822 Liver .a 1950 to 2624 1 to 674   tiling clone,   674/674
(100 %)
4 diff
(99.5 %id)
R89611 liver and spleen .a 1960 to 2372 421 to 3       419/421
(99 %)
0 diff
(100 %id)
BF798043 lymph, lymphoma, cell line .b 1 to 721 1 to 725   tiling clone,   725/1046
(69 %)
15 diff
(98.6 %id)
BX369816 Neuroblastoma Cot 50-normalized .b 484 to 1371 1 to 881   tiling clone,   881/888
(99 %)
14 diff
(98.5 %id)
AK310194 breast, tumor tissue .c 1 to 1213 2 to 1214 exact tiling clone,   1214/1214
(100 %)
0 diff
(100 %id)
AI564487 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 717 to 1241 526 to 1       526/547
(96 %)
18 diff
(96.8 %id)
BM083884 Prostate .c 777 to 1459 683 to 1   tiling clone,   683/683
(100 %)
4 diff
(99.5 %id)
CR741058 Prostate .c 1335 to 1542 1 to 209       209/216
(96 %)
7 diff
(96.8 %id)
CN357432 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 1439 to 2012 1 to 575   tiling clone,   575/576
(99 %)
3 diff
(99.5 %id)
AI675718 Prostate .c 1693 to 2056 364 to 1   tiling clone,   364/364
(100 %)
1 diff
(99.8 %id)
BC014897 Uterus, leiomyosarcoma .d 1 to 2124 1 to 2124 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 2124/2124
(100 %)
3 diff
(99.9 %id)
CR993500 T-Lymphocytes .d 15 to 798 1 to 785       785/785
(100 %)
3 diff
(99.7 %id)
BG478671 melanotic melanoma, skin .d 63 to 827 1 to 770       770/914
(84 %)
20 diff
(97.9 %id)
TI_1948121593   .d 138 to 858 127 to 853   fully sequenced,   727/827
(87 %)
14 diff
(98.4 %id)
TI_1948121885   .d 138 to 755 132 to 749   fully sequenced,   618/749
(82 %)
6 diff
(99.2 %id)
TI_1948121734   .d 139 to 793 130 to 784   fully sequenced,   655/784
(83 %)
8 diff
(99.0 %id)
BQ328918 lung_normal .d 454 to 810 1 to 357       357/357
(100 %)
3 diff
(99.2 %id)
BE825704 lung_normal .d 610 to 929 349 to 30       323/349
(92 %)
0 diff
(100 %id)
TI_1948121886   .d 725 to 1104 545 to 164   fully sequenced,   382/545
(70 %)
1 diff
(99.9 %id)
TI_1948121735   .d 732 to 1128 519 to 124   fully sequenced,   396/519
(76 %)
0 diff
(100 %id)
TI_1948121594   .d 797 to 1128 467 to 135   fully sequenced,   333/467
(71 %)
6 diff
(98.8 %id)
EC583631 Prostate .d 1919 to 2039 1 to 124       124/124
(100 %)
4 diff
(96.8 %id)
DA359576 subthalamic nucleus .d 1927 to 2492 2 to 568   tiling clone, capped   567/567
(100 %)
2 diff
(99.7 %id)
EC531844 Prostate .d 1931 to 2036 1 to 105       105/105
(100 %)
3 diff
(97.2 %id)
EC536593 Prostate .d 1932 to 2050 1 to 115       115/116
(99 %)
6 diff
(94.9 %id)
EC517003 Prostate .d 1933 to 2049 1 to 115       115/115
(100 %)
4 diff
(96.6 %id)
BE928231 colon .d 1936 to 2328 401 to 10       392/401
(97 %)
0 diff
(100 %id)
BG168885 hypernephroma, cell line, Kidney .d 1947 to 2630 1 to 680       680/943
(72 %)
31 diff
(96.8 %id)
BQ344656 nervous_tumor .d 1965 to 2372 14 to 420       407/420
(96 %)
6 diff
(98.6 %id)
EC551091 Prostate .d 1974 to 2083 1 to 110       110/110
(100 %)
1 diff
(99.1 %id)
EC443716 Prostate .d 1982 to 2090 7 to 111       105/111
(94 %)
6 diff
(94.6 %id)
EC442336 Prostate .d 2027 to 2127 1 to 101       101/103
(98 %)
4 diff
(96.2 %id)
EC454869 Prostate .d 2030 to 2123 1 to 93       93/97
(95 %)
3 diff
(97.0 %id)
EC473907 Prostate .d 2031 to 2123 1 to 93       93/97
(95 %)
1 diff
(99.0 %id)
BF797360 lymph, lymphoma, cell line .d 2079 to 2794 1 to 716       716/766
(93 %)
26 diff
(96.7 %id)
BG676440 skin, squamous cell carcinoma .d 2099 to 2901 1 to 810       810/942
(85 %)
32 diff
(96.7 %id)
BI335262 cervical carcinoma cell line, cervix .d 2121 to 3004 1 to 884       884/884
(100 %)
26 diff
(97.1 %id)
CV571115 cornea, eye .d 2133 to 2733 1 to 601       601/601
(100 %)
0 diff
(100 %id)
CX758792 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 2249 to 2982 1 to 733   tiling clone, Submitted on the opposite strand 733/733
(100 %)
6 diff
(99.2 %id)
BQ946735 sciatic nerve .d 2368 to 3008 1 to 648       648/920
(70 %)
12 diff
(98.7 %id)
AL523555 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 2489 to 3606 1108 to 1       1108/1144
(96 %)
28 diff
(97.6 %id)
BG984997 colon_normal .d 2565 to 2960 396 to 1       396/396
(100 %)
4 diff
(99.0 %id)
BX403127 Neuroblastoma Cot 25-normalized .d 2581 to 3603 1023 to 1       1023/1023
(100 %)
22 diff
(97.9 %id)
BQ301672 bocio_tumor .d 2603 to 2974 1 to 373       373/373
(100 %)
9 diff
(97.6 %id)
BF028013 bladder, carcinoma, cell line .d 2618 to 3313 1 to 696       696/829
(83 %)
46 diff
(94.5 %id)
BI054100 placenta_normal .d 2651 to 3028 1 to 381       381/382
(99 %)
12 diff
(96.9 %id)
AW900025 nervous_normal .d 2652 to 2876 231 to 1       231/243
(95 %)
14 diff
(94.3 %id)
BE161065 head_neck .d 2679 to 3268 591 to 1     Submitted on the opposite strand 591/593
(99 %)
4 diff
(99.4 %id)
BI047744 stomach .d 2739 to 3205 476 to 9       468/476
(98 %)
0 diff
(100 %id)
BQ321202 colon .d 2742 to 3054 324 to 14       311/324
(95 %)
0 diff
(100 %id)
BQ321174 colon .d 2783 to 3075 1 to 293       293/293
(100 %)
5 diff
(98.3 %id)
AW811605 stomach .d 2829 to 3006 18 to 191       174/191
(91 %)
6 diff
(96.9 %id)
BG108042 Bone, osteosarcoma, cell line .d 2835 to 3562 1 to 728   tiling clone,   728/730
(99 %)
1 diff
(99.9 %id)
BE179863 head_neck .d 2904 to 3108 215 to 11     Submitted on the opposite strand 205/215
(95 %)
0 diff
(100 %id)
BF796139 lymph, lymphoma, cell line .d 2922 to 3618 1 to 709       709/822
(86 %)
20 diff
(97.6 %id)
BQ371773 prostate_normal .d 2923 to 3212 1 to 290       290/293
(98 %)
13 diff
(95.6 %id)
AW900350 nervous_normal .d 2933 to 3225 2 to 293       292/293
(99 %)
7 diff
(97.7 %id)
BF746708 breast .d 2979 to 3228 1 to 248       248/307
(80 %)
12 diff
(96.1 %id)
BE768607 prostate_tumor .d 3118 to 3410 296 to 4       293/296
(98 %)
0 diff
(100 %id)
BE768740 prostate_tumor .d 3118 to 3406 296 to 8       289/296
(97 %)
0 diff
(100 %id)
BE812970 amnion_normal .d 3118 to 3260 196 to 54       143/196
(72 %)
0 diff
(100 %id)
BI857472 breast, mammary adenocarcinoma, cell line .d 3119 to 3617 1 to 499   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 499/499
(100 %)
4 diff
(99.2 %id)
TI_57187438   .d 3119 to 3617 54 to 552   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 499/499
(100 %)
4 diff
(99.2 %id)
AW439494 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 3142 to 3618 481 to 5   tiling clone,   477/481
(99 %)
0 diff
(100 %id)
BQ341185 nervous_normal .d 3158 to 3500 1 to 343       343/360
(95 %)
2 diff
(99.5 %id)
AW148750 brain, tumor, 5 pooled (see description) .d 3169 to 3613 445 to 1       445/445
(100 %)
0 diff
(100 %id)
AI636628 Kidney, renal cell tumor .d 3218 to 3613 398 to 1       398/398
(100 %)
4 diff
(99.0 %id)
AI989336   .d 3223 to 3452 230 to 1       230/230
(100 %)
1 diff
(99.6 %id)
AI860368 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 3223 to 3618 396 to 1       396/396
(100 %)
2 diff
(99.5 %id)
BQ369826 placenta_normal .d 3231 to 3521 25 to 316       292/316
(92 %)
7 diff
(97.8 %id)
BF095588 uterus_tumor .d 3236 to 3521 286 to 1       286/286
(100 %)
0 diff
(100 %id)
AA216378   .d 3272 to 3604 377 to 45       333/378
(88 %)
0 diff
(100 %id)
AA508878 Prostate .d 3276 to 3558 1 to 283       283/316
(89 %)
5 diff
(98.5 %id)
AA523352 metastatic prostate bone lesion .d 3285 to 3613 351 to 23   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 329/336
(97 %)
1 diff
(99.8 %id)
AA732366 germinal center B cell .d 3296 to 3616 327 to 7       321/327
(98 %)
0 diff
(100 %id)
BI856806 breast, mammary adenocarcinoma, cell line .d 3303 to 3613 1 to 309   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 309/309
(100 %)
2 diff
(99.4 %id)
TI_57190483   .d 3303 to 3613 56 to 364   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 309/309
(100 %)
2 diff
(99.4 %id)
AA639027 Ewing's sarcoma .d 3413 to 3618 208 to 3       206/209
(98 %)
0 diff
(100 %id)
C00869   .d 3433 to 3617 1 to 185       185/185
(100 %)
0 diff
(100 %id)
AK090834 amygdala .e 1 to 2078 39 to 2116 exact tiling clone, available from FLJ,   2078/2116
(98 %)
27 diff
(98.8 %id)
AX746643   .e 1 to 2078 39 to 2116 exact     2078/2116
(98 %)
27 diff
(98.8 %id)
DA148414 amygdala .e 1 to 535 39 to 573   capped   535/572
(93 %)
6 diff
(99.0 %id)
DB301588 amygdala .e 1555 to 2078 525 to 1       525/525
(100 %)
18 diff
(96.6 %id)
BP315642 mammary gland .f 1 to 580 1 to 581 N45S tiling clone,   581/581
(100 %)
3 diff
(99.5 %id)
BU633402 cell lines, Chondrosarcoma .g 1 to 715 731 to 19 P7Q D8I R9E D10T H11T ... tiling clone, AAA   713/713
(100 %)
4 diff
(99.5 %id)
BU633929 cell lines, Chondrosarcoma .g 170 to 767 616 to 19   tiling clone, AAA   598/598
(100 %)
1 diff
(99.9 %id)
CB046919 2 pooled tumors (clear cell type), Kidney .g 226 to 571 10 to 355   fully sequenced,   346/355
(97 %)
7 diff
(98.1 %id)
CB046692 2 pooled tumors (clear cell type), Kidney .g 244 to 381 139 to 276   fully sequenced,   138/276
(50 %)
6 diff
(97.9 %id)
AI949987 2 pooled tumors (clear cell type), Kidney .g 268 to 715 460 to 13   AAA   448/448
(100 %)
0 diff
(100 %id)
AW194161 serous papillary carcinoma, high grade, 2pooled tumors, uterus .g 270 to 497 228 to 1       228/228
(100 %)
2 diff
(99.2 %id)
AW615497 lung, small cell carcinoma .g 270 to 716 450 to 4       447/450
(99 %)
0 diff
(100 %id)
BF197303 Kidney .g 276 to 716 451 to 11       441/451
(97 %)
0 diff
(100 %id)
CB046691 2 pooled tumors (clear cell type), Kidney .g 320 to 715 426 to 31   fully sequenced, AAA   396/396
(100 %)
0 diff
(100 %id)
AW013907   .g 334 to 715 399 to 18   AAA   382/382
(100 %)
2 diff
(99.5 %id)
CB046918 2 pooled tumors (clear cell type), Kidney .g 541 to 715 241 to 67   fully sequenced, AAA   175/175
(100 %)
0 diff
(100 %id)
GD154278   .g 600 to 716 1 to 118       118/130
(90 %)
4 diff
(97.0 %id)
BQ954359 sciatic nerve .h 1 to 775 12 to 795 exact tiling clone,   784/911
(86 %)
21 diff
(97.7 %id)
AK094987 hippocampus .i-u 1 to 3497 2 to 3495 exact tiling clone, available from FLJ,   3495/3495
(100 %)
12 diff
(99.7 %id)
DA298192 hippocampus .i-u 1 to 573 2 to 575 exact capped   574/574
(100 %)
2 diff
(99.7 %id)
DB307903 hippocampus .i-u 2956 to 3497 542 to 1       542/542
(100 %)
9 diff
(98.4 %id)
DW408569 Liver .j-u -9 to 318 17 to 343   tiling clone,   327/343
(95 %)
11 diff
(96.8 %id)
BF110446 carcinoid, lung .j-u 274 to 887 614 to 1 E28K tiling clone,   614/614
(100 %)
2 diff
(99.7 %id)
AW341014 carcinoid, lung .j-u 458 to 883 426 to 1       426/426
(100 %)
0 diff
(100 %id)
BU619884 Cell Line, Chondrosarcoma .k-u 1 to 540 553 to 14 M12L E13G tiling clone, AAA   540/540
(100 %)
13 diff
(97.6 %id)
CV357419 stomach .l-u 1 to 150 37 to 184 L14W E15R V16C L17* tiling clone,   152/184
(82 %)
6 diff
(96.8 %id)
TI_1948121449   Gene MCCC2, variant not shown       fully sequenced, This clone was ignored    
TI_1948121450   Gene MCCC2, variant not shown       fully sequenced, This clone was ignored    
AA641596   Gene MCCC2, variant not shown         Suspected internal deletion, this clone was ignored    
AI869038 Prostate Gene MCCC2, variant not shown         This clone was ignored    
BE408282 choriocarcinoma, placenta Gene MCCC2, variant not shown         This clone was ignored    
TI_1948216501   Gene MCCC2, variant not shown         This clone was ignored    
TI_1948216502   Gene MCCC2, variant not shown         This clone was ignored    
TI_1948216654   Gene MCCC2, variant not shown       fully sequenced, This clone was ignored    
TI_1948216655   Gene MCCC2, variant not shown       fully sequenced, This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j-u, .k-u, .l-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC